Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACSL3 pseudogene 1 (ACSL3P1) is a pseudogene related to the functional enzyme acyl-CoA synthetase long-chain family member 3 (ACSL3). Pseudogenes are segments of DNA that resemble functional genes but are typically non-coding, lacking the ability to produce a protein or perform the biochemical activities of their parent gene. ACSL3P1 does not encode a protein and is not considered a therapeutic target, unlike ACSL3, which plays a central role in the activation of long-chain fatty acids and lipid metabolism. Confusion arises because pseudogene symbols like ACSL3P1 may appear in genomic databases, but only ACSL3, not its pseudogene(s), is a biologically and pharmacologically important target[2][3][7]. If you need details for the functionally relevant enzyme, refer to ACSL3 (Acyl-CoA synthetase long-chain family member 3), not ACSL3 pseudogene 1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACSL3 pseudogene 1 (ACSL3P1).